Update on ISIS Response to FDA Statement on ESIs
In response to the FDA statement released on April 23rd, addressing the safety and effectiveness of epidural steroid injections.
ISIS feels that the alert was misleading in its message regarding the safety of epidural steroid injections and contained inaccuracies regarding the effectiveness of this procedure.
The statement was released by the regulatory division of the FDA and not the FDA Safe Use Initiative (SUI). The FDA SUI has been working with physician experts from multiple organizations, including several ISIS leaders, over the past two years to help create a set of expert recommendations for the safe administration of epidural steroid injections. It is important to note that the release of the April 23 statement by the FDA regulatory branch was unilateral and unbeknownst to the panel of experts working with the SUI on epidural steroid injections. Following the release of this statement, the expert panel leaders on this project decided to involve the 14 societies represented on the Multi-Society Pain Workgroup (MPW) to craft a set of consensus recommendations for the safe administration of epidural steroid injections... Read More
Radiofrequency Bio-Skills Lab
October 10-12, 2014
Now Open for Registration!
Physician Member: $2,500 - Register Now!
Earn 16 AMA PRA Category 1 Credit(s)™
During this 16-hour radiofrequency procedures course the following techniques will be taught:
- L2-4 Medial Branch
- L5 Dorsal Ramus
- Lumbar Difficult Anatomy
- Third Occipital Nerve (TON)
- C3-6 Medial Branch
- C7 Medial Branch
In addition, there will be lectures and didactics covering:
- Anatomy of Cervical and Lumbar Posterior Columns
- Lumbar and Cervical Medial Branch Blocks
- Radiofrequency Principles
- Lumbar and Cervical Radiofrequency
- Lumbar and Cervical Case Management
ISIS OFFERS GROUP PURCHASING TO MEMBERS FOR INCREDIBLE SAVINGS!
After thoroughly investigating numerous options, in response to the vexing single dose vial issues and escalating supply costs, the ISIS leadership is happy to announce the formation of a unique partnership with PedsPal, a national physician Group Purchasing Organization, or GPO. Working with ISIS, PedsPal has structured a discount program that is only available to ISIS members. The program is specifically targeted to offer the best pricing on the medications, equipment and supplies that are most important to you. As an example, through the GPO plan, Omnipaque 240 mg/50 ml can be purchased as low as $4.37 per vial. MORE...